Ultragenyx Pharmaceutical
RARE
29,58 €
Share price
-7.69%
Change (1 day)
-31.91%
Change (1 year)
Categories
EPS for Ultragenyx Pharmaceutical (RARE)
EPS in 2023 (TTM): -9,78 €
According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -9,34 €. In 2022 the company made an earnings per share (EPS) of -9,22 € a decrease over its 2021 EPS that were of -6,12 €.
EPS history for Ultragenyx Pharmaceutical from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -9,78 € | 6.06% |
| 2022 | -9,22 € | 50.67% |
| 2021 | -6,12 € | 113.69% |
| 2020 | -2,86 € | -55.9% |
| 2019 | -6,49 € | 82.56% |
| 2018 | -3,56 € | -45.15% |
| 2017 | -6,49 € | 14.68% |
| 2016 | -5,66 € | 57.36% |
| 2015 | -3,59 € | 69.83% |
| 2014 | -2,12 € | 15.22% |
| 2013 | -1,84 € |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | 0,71 € | -107.60% | 🇺🇸 USA |
 | -0,58 € | -93.75% | 🇺🇸 USA |
 | -2,57 € | -72.46% | 🇺🇸 USA |
 | -0,62 € | -93.36% | 🇺🇸 USA |